Omega Fund Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Hold |
1,788,160
| – | – | 0.81% | 12 |
|
|
2025
Q1 | $1.95M | Hold |
1,788,160
| – | – | 1.15% | 11 |
|
|
2024
Q4 | $1.79M | Hold |
1,788,160
| – | – | 1.16% | 9 |
|
|
2024
Q3 | $2.95M | Hold |
1,788,160
| – | – | 1.84% | 9 |
|
|
2024
Q2 | $1.98M | Hold |
1,788,160
| – | – | 1.47% | 9 |
|
|
2024
Q1 | $2.36M | Hold |
1,788,160
| – | – | 1.52% | 8 |
|
|
2023
Q4 | $2.68M | Hold |
1,788,160
| – | – | 2.17% | 11 |
|
|
2023
Q3 | $2.63M | Hold |
1,788,160
| – | – | 2.41% | 8 |
|
|
2023
Q2 | $4.49M | Hold |
1,788,160
| – | – | 2.51% | 10 |
|
|
2023
Q1 | $2.66M | Hold |
1,788,160
| – | – | 1.74% | 11 |
|
|
2022
Q4 | $2.5M | Hold |
1,788,160
| – | – | 0.84% | 12 |
|
|
2022
Q3 | $5.65M | Hold |
1,788,160
| – | – | 2.07% | 10 |
|
|
2022
Q2 | $6.21M | Hold |
1,788,160
| – | – | 1.98% | 11 |
|
|
2022
Q1 | $20.2M | Hold |
1,788,160
| – | – | 4.14% | 7 |
|
|
2021
Q4 | $17.1M | Hold |
1,788,160
| – | – | 2.42% | 9 |
|
|
2021
Q3 | $15.8M | Hold |
1,788,160
| – | – | 1.78% | 11 |
|
|
2021
Q2 | $21.9M | Hold |
1,788,160
| – | – | 2.48% | 8 |
|
|
2021
Q1 | $28.5M | Hold |
1,788,160
| – | – | 2.7% | 9 |
|
|
2020
Q4 | $27.3M | Hold |
1,788,160
| – | – | 4.1% | 7 |
|
|
2020
Q3 | $33.2M | Buy |
1,788,160
+416,666
| +30% | +$7.74M | 8.98% | 4 |
|
|
2020
Q2 | $16.6M | Hold |
1,371,494
| – | – | 4.55% | 5 |
|
|
2020
Q1 | $8.3M | Hold |
1,371,494
| – | – | 3.43% | 6 |
|
|
2019
Q4 | $13.3M | Hold |
1,371,494
| – | – | 4.23% | 5 |
|
|
2019
Q3 | $13.7M | Hold |
1,371,494
| – | – | 4.23% | 5 |
|
|
2019
Q2 | $15.7M | Buy |
+1,371,494
| New | +$15.7M | 4.01% | 5 |
|